Ocular Therapeutix, Inc. (OCUL)
6.87
-0.51
(-6.91%)
USD |
NASDAQ |
Oct 16, 16:00
6.91
+0.04
(+0.58%)
After-Hours: 20:00
Ocular Therapeutix Free Cash Flow (Quarterly) : -70.64M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -70.64M |
| March 31, 2026 | -70.66M |
| December 31, 2025 | -57.09M |
| September 30, 2025 | -56.72M |
| June 30, 2025 | -56.48M |
| March 31, 2025 | -46.60M |
| December 31, 2024 | -39.63M |
| September 30, 2024 | -36.65M |
| June 30, 2024 | -25.54M |
| March 31, 2024 | -34.14M |
| December 31, 2023 | -17.73M |
| September 30, 2023 | -13.18M |
| June 30, 2023 | -22.06M |
| March 31, 2023 | -23.35M |
| December 31, 2022 | -19.11M |
| September 30, 2022 | -13.96M |
| June 30, 2022 | -11.37M |
| March 31, 2022 | -18.88M |
| December 31, 2021 | -15.78M |
| September 30, 2021 | -13.26M |
| June 30, 2021 | -20.18M |
| March 31, 2021 | -17.52M |
| December 31, 2020 | -6.499M |
| September 30, 2020 | -13.87M |
| June 30, 2020 | -14.92M |
| Date | Value |
|---|---|
| March 31, 2020 | -19.10M |
| December 31, 2019 | -20.66M |
| September 30, 2019 | -19.37M |
| June 30, 2019 | -19.67M |
| March 31, 2019 | -20.11M |
| December 31, 2018 | -14.13M |
| September 30, 2018 | -11.35M |
| June 30, 2018 | -12.79M |
| March 31, 2018 | -12.85M |
| December 31, 2017 | -10.95M |
| September 30, 2017 | -16.42M |
| June 30, 2017 | -15.13M |
| March 31, 2017 | -16.23M |
| December 31, 2016 | -8.292M |
| September 30, 2016 | -8.20M |
| June 30, 2016 | -10.04M |
| March 31, 2016 | -9.383M |
| December 31, 2015 | -9.109M |
| September 30, 2015 | -9.776M |
| June 30, 2015 | -9.403M |
| March 31, 2015 | -7.233M |
| December 31, 2014 | -6.067M |
| September 30, 2014 | -6.607M |
| June 30, 2014 | -4.76M |
| March 31, 2014 | -4.322M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| EyePoint, Inc. | -63.55M |
| ANI Pharmaceuticals, Inc. | 53.62M |
| Eli Lilly & Co. | 4.475B |
| Corcept Therapeutics, Inc. | 31.02M |
| Veru, Inc. | -5.467M |